Over 50% cut in stent prices has not lowered treatment cost for patients

NPPA had slashed prices of drug eluting stents& bioresorable vascular scaffolds as it found companies were making nearly 400% profits on these stents in India.
Source: The Economic Times - Category: Consumer Health News Source Type: news
More News: Health | India Health